NCT01356472View on ClinicalTrials.gov

Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia

PHASE4UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2013

Conditions
Methicillin-resistant Staphylococcus AureusPneumonia, Ventilator-Associated
Interventions
DRUG

Imipenem/cilastatin

the intervention group was designed for combined linezolid plus imipenem for treating MRSA VAP

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Ruijin Hospital

OTHER